Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Stella is very careful with the information she releases to not attract pump and dumpers and put forth meaningful PR info. Be patient.
Amen.
I have quite a bit more shares than that, and although looking at the stock day to day hurts. I'm still not going to sell for at least another year or so when we start to see growth of product demand, revenues, license agreements that will actually contribute to the bottom like etc.....
Market cap is low, if we can get even a few million of revenue, thing will fly.
Ryan
They are not restricted shares?
This stock will pay great dividends for those who are committed and patient. I have held this for a few years and I will not sell until it hits .15-.25 in 2 years
I see the next 30 days being a ride to over .04
Accumulated at .0167 today.
This is thin, 2 green days and we should be in .03
Maybe I will sell at 30$ a share, probably not though.
Great news. Awesome report. This should be slow and steady for share price.
In addition to the Doc Green’s topical cannabis cream, which is already available in dispensaries in California, Honeywood has developed Vapura, a medicinal cannabis vapor cartridge that attaches to an e-cigarette battery and produces an effective and flavorful cannabis vapor. We anticipate that Vapura will be available for patients in compliance with California Health & Safety Code 11362.5 beginning in the third quarter of 2014.
Tauriga’s natural wellness business also includes “Cannabis Complements,” a line of non-cannabis containing dietary supplements which is being launched this summer. These dietary supplements will target cannabis-related effects, such as anxiety, memory and cognitive function, and appetite control. The supplements do not contain cannabis and can be sold nationwide to establish and build the Tauriga brand, especially in the 23 states where medicinal marijuana is legal.
This is one of the most accurate, straightforward statements posted on this board.
Wonderful News!
Most of that is in the risk section which they have to say to prevent lawsuits that they previously have had in past with IMUN due to investors thinking profits are guaranteed. It's to protect them from losing lawsuits on class action from dumb investors. Revenues will be generated they just can't guarantee it. Doc Greens IMO will be huge as well as Pilus. So not reason why this stock won't be .25 minimum 1 year from now. I also think the stock is much more stable right now then it will ever be. Most large bulk investors that wanted out have already sold. Let it ride, let the people who want in pay .06-.08 for the next week or so. Slap that ask...long term on TAUG. Could be once in a lifetime opportunity if all goes well.
-Ryan
Sit back, relax, and enjoy the relatively short term ride to quarter town!
Cramer Executive Decision with BDSI
Endo and BioDelivery Sciences announce positive top-line results from the Phase III clinical trial of BEMA®
Volume picking up. On set for .0625 close.
We are going higher. Loaded up today at lows. TAUG
Today's chart is nothing short of impressive
This stock is a sleeper. Just wait until this momentum continues.
.06 or higher easy...after weedstock/July 10 agreement.
This recent news is worth bigger than 52 highs
Tauriga Sciences (OTC: TAUG) announced Tuesday that the company will be presenting at the first annual WeedStock conference.
Tauriga is reinventing itself as a leader in the marijuana sector, with CEO Dr. Stella Sung at the helm. The company is no longer dependent on a single license, but is creating a diversified portfolio of assets -- including licensing agreements and acquisitions of companies in the life science technology industry.
The company put themselves in the center of the marijuana space with the acquisition of Honeywood earlier in 2014. Honeywood makes cannabis oil infused topical creams to alleviate pain, while providing no psychoactive effects.
Related: Tauriga Sciences Is Poised To Establish itself In The Marijuana Industry
Sung commented on the benefit that the creams can provide the elderly population, who, “are already taking a lot of oral medications and don’t want to take any more due to the fear of sides effects from drug-drug interactions, but do suffer from pain and discomfort.”
Tauriga plans to emphasize dispensaries for distribution, but doesn’t want to limit itself from other distribution channels.
Tauriga recently brought Dr. Lawrence May, MD, onto the team. Prior to his engagement with Tauriga, May served as the executive vice president for medical and scientific affairs at Herbalife. Sung commented, “I think his background is perfect for developing supplements related to cannabis effects [including] memory and cognitive issues, appetite, and depression.”
Changing product offerings is not all Tauriga is doing to fuel a turnaround. Because the company is now able to acquire capital at a lower cost, Tauriga has been replacing past debts. $800,000 was raised in a recent private placement, while over $700,000 of older convertible notes were paid off.
Tauriga sciences will be presenting its opportunities at 10:00 a.m. on July 1 at the exclusive WeedStock conference.
Related Links
Tauriga Sciences Is Poised To Establish Themselves In The Marijuana Space (Part Two)
Crossover, Alternative Car Sales Helped Boost May Auto Industry Figures
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Why is this not moving?
I'm not selling until 25-30$
FDA approved. !!!!!!!!!!!!
LOS ANGELES, May 29, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company with a proprietary microbial fuel cell technology and a pending acquisition in the medicinal cannabis space, has entered into its first retail distribution agreement for its new line of natural medicine products. Tauriga's natural medicine product line is expected to launch this summer and will include non-cannabis containing candies, gums and supplements with proprietary formulations designed to address unwanted cannabis-related effects such as increased appetite, anxiety, and reduction in memory and cognitive function. The Company's first retail distribution agreement for these products is with SpeedWeed, a leading medical marijuana delivery service serving areas of Southern California in strict accordance with California regulations and health and safety codes.
Tauriga's cannabis-free natural medicine products have been developed for medical marijuana patients by Dr. Lawrence May, Tauriga's Chief Medical Officer and former Executive Vice President and Chairman of the Medical Advisory Board of Herbalife International. Dr. May states, "We believe that there is an important market need for premium natural health care products for the growing population of legitimate marijuana patients. Tauriga's new product line uses ingredients that are classified as 'generally recognized as safe' (GRAS) and that are supported by scientific and clinical literature."
SpeedWeed founder and CEO, A.J. Gentile, added, "We are pleased to serve as a retail distributor and test market for Tauriga's innovative natural medicine products. We believe these products can improve the experiential component for our clients, and our ability to offer new ancillary products is another example of our commitment to customer service. We look forward to further developing our relationship with Tauriga as we continue to grow our customer base with high customer ratings."
Tauriga plans to increase its presence in the overall natural medicine sector beyond medicinal cannabis-containing products. Company Chairman & CEO, Dr. Stella M. Sung states, "Ultimately, we hope to launch an integrated family of natural health care products that will improve the overall experience of the medical marijuana patient and encourage them to use medical marijuana responsibly. Furthermore, we believe our non-cannabis products may be sold through many different channels, which will potentially allow us to more quickly access markets and early revenues."
Fantastic find!!!! That is amazing news. Good connections. If data proofs this is massive.
Most of the people on this board want to flip this stock and hope to double in days. If it doesn't happen they bash it. Do any of you know how to actual invest in a developing company? It doesn't happen overnight, if you're looking for that- play the lottery or high stakes slots. This company has untapped potential, 2 solid industries with extreme growth potential. Have to trust the solid management team to deliver and take the company to revenue land.
No worries all the flippers are out now. Much more support.
Dime bound this week
Close above .08????
Awesome video. Exciting!!!
Monday we back to .072 I can't wait for the open!
Added big here, bounce coming within few hours back to above .062
Cheap shares!!! Time for rebound :)
Slow and steady wins the race. Less volatile too.
Solid statement. Very true.
Lol it will be back to .108 in no time buy these cheaps I got orders in